HOXB7 | Homeobox B7 | Predicted intracellular proteins Transcription factors
| | | | | Mixed |
HSF1 | Heat shock transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
HSF2 | Heat shock transcription factor 2 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ID2 | Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ID3 | Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
IRF1 | Interferon regulatory factor 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
IRF2 | Interferon regulatory factor 2 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
IRF3 | Interferon regulatory factor 3 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
IRF7 | Interferon regulatory factor 7 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
JUNB | Jun B proto-oncogene | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
JUND | Jun D proto-oncogene | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
KDM2A | Lysine (K)-specific demethylase 2A | Enzymes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
KDM5B | Lysine (K)-specific demethylase 5B | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
LYAR | Ly1 antibody reactive | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
MAX | MYC associated factor X | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MBD1 | Methyl-CpG binding domain protein 1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MEF2A | Myocyte enhancer factor 2A | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MEF2C | Myocyte enhancer factor 2C | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MEF2D | Myocyte enhancer factor 2D | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MIER1 | Mesoderm induction early response 1, transcriptional regulator | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MTA2 | Metastasis associated 1 family, member 2 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MTF1 | Metal-regulatory transcription factor 1 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MYC | V-myc avian myelocytomatosis viral oncogene homolog | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NCOA3 | Nuclear receptor coactivator 3 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NCOR1 | Nuclear receptor corepressor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFATC2 | Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFE2L2 | Nuclear factor, erythroid 2-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFIA | Nuclear factor I/A | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFIB | Nuclear factor I/B | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NFIC | Nuclear factor I/C (CCAAT-binding transcription factor) | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NFYA | Nuclear transcription factor Y, alpha | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NFYB | Nuclear transcription factor Y, beta | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NKX6-1 | NK6 homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NONO | Non-POU domain containing, octamer-binding | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PAX2 | Paired box 2 | Disease related genes Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Group enriched |
PAX6 | Paired box 6 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PHF5A | PHD finger protein 5A | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |